Published on
May 7, 2026
- 13:33 GMT
Profil expands global metabolic trial capabilities with new US clinical research unit
DüSSELDORF, GERMANY, May 7, 2026 /EINPresswire.com/ -- Profil, the leading full-service CRO for early-phase clinical trials in the field of metabolic disorders, today announced the expansion of its clinical operations to Houston (Webster), Texas through …
Distribution channels:
Companies, Healthcare & Pharmaceuticals Industry
...
